title: Oral Nutrient Supplementation and Cognitive Function--Reply.
authors.affiliation: Clinical Trials Branch, National Institutes of Health, Bethesda, Maryland.
authors.forename: Emily Y
authors.initials: EY
authors.lastname: Chew
authors.affiliation: Neuroepidemiology Section, National Institutes of Health, Bethesda, Maryland.
authors.forename: Lenore
authors.initials: L
authors.lastname: Launer
authors.affiliation: Moran Eye Center, University of Utah, Salt Lake City.
authors.forename: Paul
authors.initials: P
authors.lastname: Bernstein
mesh_terms: D003071:Cognition; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000008:administration & dosage*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D014975:Lutein / Q000008:administration & dosage*; D008268:Macular Degeneration / Q000628:therapy*; D008297:Male; D014815:Vitamins / Q000008:administration & dosage*; D065146:Zeaxanthins / Q000008:administration & dosage*
chemical_list: D014815:Vitamins; D065146:Zeaxanthins; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid; D014975:Lutein
references.citation: Arch Intern Med. 2007 Nov 12;167(20):2184-90
references.pmid: 17998490
references.citation: Alzheimers Dement. 2010 Nov;6(6):456-64
references.pmid: 20434961
references.citation: Psychopharmacology (Berl). 2013 Feb;225(3):605-12
references.pmid: 22932777
references.citation: PLoS One. 2015 Mar 18;10(3):e0120391
references.pmid: 25786262